Abstract: a conceptually new, two-step synthesis of medicinally important 1,2,4-triazoles from isocyanides and thiosemicarbazones was developed. The method is based on the recently discovered TMSCl-promoted reaction of isocyanides that yields rare N 1 ,N 3 -disubstututed formamidrazones.
Introduction
The synthetic utility of isocyanides extends far beyond the preparation of -acyloxy and - vasopressin V 1A receptor antagonist 2, 8 Ras farnesyl transferase inhibitor 3, 9  opioid receptor antagonist 4, 10 tubulin polymerization inhibitor 5, 11 high-affinity ligand to the human ghrelin receptor 6 12 and glycine transporter 1 inhibitor 7 13 are only a few examples illustrating the privileged character 14 of the 1,2,4-triazole core for the drug design ( Figure 1 ). Recently, we described a new reaction of isocyanides with aldehyde thiosemicarbazones 8 that yields rare N 1 ,N 3 -disubstituted formamidrazone hydrochlorides 9. 15 The reaction is promoted by chlorotrimethylsilane (TMSCl) and is thought to proceed via isocyanide N-H insertion followed by the elimination of isothiocyanic acid (Scheme 2). Given the novelty of this reaction and an intriguing arrangement of potentially reactive electrophilic hydrazone and nucleophilic amidine moieties in 9, we became interested in identifying the utility of the latter for ring-forming processes. 16 Herein we described the application of isocyanide-derived formamidrazones 9 toward facile preparation of diversely substituted 1,2,4-triazoles.
Scheme 2.
TMSCl-promoted reaction of isocyanides with aldehyde thiosemicarbazones. 15 
Results and discussion
As we reported earlier, 15 in some cases formamidrazone hydrochlorides 9 precipitate from the reaction mixture and can be conveniently isolated and characterized. Their free-base counterparts 10, however, exist as a mixture of tautomers (presumably, 10' and 10'') that complicate their spectroscopic characterization. In principle, ring tautomer 10''' could also exist in equilibrium with the open-chain tautomers 10' and 10'' (although only two major tautomers could be detected by 1 H NMR spectroscopy). We reasoned that if this was the case, 2,3-dihydro-1,2,4-triazole 10''' could be aromatized under appropriate dehydrogenation conditions and thus provide a convenient access to 1,2,4-triazoles 11 (Scheme 3).
Scheme 3.
The rationale for the formation of 1,2,4-triazoles.
A model formamidrazone hydrochloride 9a (R 1 = 3-chlorophenyl, R 2 = t-Bu) that was prepared in high yield (90%) and isolated, in analytically pure form, from the TMSClpromoted reaction of t-BuNC with 3-chlorobenzaldehyde thiosemicarbazone 15 The newly established synthetic approach was applied to a diverse range of free-base formamidrazones 10b-z that were also prepared via the TMSCl-promoted reaction of thiosemicarbazones 8 with aliphatic isocyanides, followed by basic work-up of the reaction mixture. In principle, the crude formamidrazones could be used in the dehydrogenative cyclization step directly (Scheme 4). However, better yields and easier purification of the target 1,2,4-triazoles were obtained from formamidrazones that were briefly fractionated by silica gel chromatography to achieve at least 80% purity (as judged by LC MS analysis). The isolated yields of the 1,2,4-triazoles 11b-z from thiosemicarbazones 8, were fair to excellent (Table 1) . 20 Notably, when we repeated the synthesis of 11a without the isolation of 9a and proceeded with the basic workup of the reaction mixture and fractionation of the free-base product, the yield of 11a was even slightly higher (76%) than that obtained via isolation of the formamidrazone hydrochloride by filtration (possibly due to a partial solubility of 9a in acetonitrile). 
Conclusion
In conclusion, we have described a conceptually new preparation of 1,2,4-triazoles and the first practical application of the rare, isocyanide-derived
formamidrazones in heterocycle synthesis. Our convergent and technically simple approach significantly extends the modern arsenal of methods to prepare this important class of heterocyclic compounds.
Experimental Section.

General
Dry acetonitrile (MeCN) was obtained by passing commercially available predried, oxygenfree formulations through activated alumina columns. All other compounds were used as received from the suppliers. The crude reaction mixtures were concentrated under reduced pressure by removing organic solvents on rotary evaporator. Column chromatography was performed using silica gel 60 (particle size 0.040-0.063 mm, 230-400 mesh ASTM).
Analytical thin-layer chromatography (TLC) was performed with silica gel 60 F254 aluminum sheets. Chemical shifts for nuclear magnetic resonance (NMR) spectra were reported in parts per million (ppm, δ) using the residual solvent peaks as internal standard.
Splitting patterns are described as singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), doublet of doublet (dd), triplet of triplet (tt), and quartet of doublet (qd). High resolution mass spectra (HRMS) were acquired using a Fourier Transform Ion Cyclotron Resonance spectrometer fitted with an electrospray source and operating in positive ion mode.
Typical procedure: Synthesis of 1,2,4-triazoles 11.
A stirred suspension (solution) of a thiosemicarbazone (1 mmol) in dry acetonitrile (10 mL)
was treated with TMSCl (1 mmol) and stirred for 10 min at r.t. An isocyanide (1.1 mmol) was added, the reaction flask was purged with argon and the reaction mixture was stirred at r.t. for 3-16 h, until TLC analysis indicated a complete disappearance of the starting thiosemicarbazone. The reaction mixture was partitioned between EtOAc and sat. aq. 
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